Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 3 1

Status

Completed 4Recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Tumor-Agnostic 5Gastrointestinal 2Sarcoma 1Genitourinary 1Endocrine 1CNS 1

Conditions

Neoplasms 5Neoplasm Metastasis 1Carcinoma, Squamous Cell 1

Interventions

Surveys and Questionnaires 65pembrolizumab 56Gemcitabine 54Paclitaxel 51Blood Specimen Collection 45Carboplatin 44Bevacizumab 41Docetaxel 38Cisplatin 33Nivolumab 32Fluorouracil 31Capecitabine 28Radiotherapy 25Pemetrexed 25Irinotecan 25Standard of Care 24Interviews as Topic 24Magnetic Resonance Spectroscopy 23Leucovorin 22Erlotinib Hydrochloride 22atezolizumab 21Cetuximab 21Afatinib 21Oxaliplatin 19trametinib 18Exercise 18Ipilimumab 17Sorafenib 16Cyclophosphamide 16olaparib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Neoplasms × irinotecan sucrosofate × Tumor-Agnostic × Clear all
NCT05382559 2026-04-14

A Study of ASP3082 in Adults With Advanced Solid Tumors

Astellas Pharma Inc

Phase 1 Recruiting
681 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT03665441 2022-10-18

Trybeca-1

ERYtech Pharma

Phase 3 Completed
512 enrolled 19 charts
Tumor-Agnostic

Neoplasms

NCT00062842 2020-03-04

Study of Irinotecan on a Weekly Schedule in Children

Baylor College of Medicine

Phase 1 Completed
23 enrolled
Tumor-Agnostic

Neoplasms

NCT00364143 2019-07-05

Safety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid Tumors

Yakult Honsha Co., LTD

Phase 1 Completed
40 enrolled
Tumor-Agnostic

Neoplasms

NCT02640365 2017-01-31

DOUBLIRI

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 1 Completed
10 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡